CEO Andrew Kuo says the investors came to the view that Taiwan needs to develop its biotechnology industries, and therefore they combined their resources to make a long-term investment in the field.
總經理郭東源指出，因為有感於台灣必須朝生物科技產業發展，因此結合資源，準備長期投入。